Novartis AG defended its stance on drug patents in an Indian court on Thursday, saying a tightening of intellectual property laws would spur investment in developing more medicines...Campaign groups are concerned that the poor could lose access to vital medications if the challenge succeeds, as many developing countries rely on generic versions of patented drugs made in India.